NCT06599931Recruiting
Cerebello-motor Neuromodulation After Stroke. CERSTIM.
CEREBELLO-MOTOR NEUROMODULATION AFTER STROKE
Source: ClinicalTrials.gov · Last updated 16 Apr 2026
Brief summary (registry, in English)
The CERSTIM study is a physiopatholgical study investigating transcranial alternating current stimulation in stroke patients in the cerebello-motor loop. The design is a cross over design testing two frequencies in the gamma band and one placebo. We will use behavioural data, functional MRI, and Electroencephalography to disentangle the effect of tACS and its frequency. Healthy participants will be also recruited.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- First submitted
- 5 Sept 2024
- Start date
- 13 Dec 2024
- Primary completion date
- 30 Jan 2027
- Lead sponsor
- Institut National de la Santé Et de la Recherche Médicale, France
- Diseases
- Stroke
- NCT number
- NCT06599931
What you commit to
- Study type: Interventional
- Planned participants: 45
- From 13 Dec 2024 to the primary completion date, 30 Jan 2027
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Conditions that are life-threatening or could compromise follow-up during the study period
- Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
Other
- \-- Pregnant and breastfeeding women
- Total paralysis of the affected hand
- Participation in another biomedical study focused on motor or overall recovery during the same period, or current exclusion period from another biomedical study
- HEALTHY
Who the study is looking for
- Male or female aged 18 years or older on the day of inclusion.
- Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.
- Ischemic stroke or intraparenchymal hematoma that occurred more than 6 months ago, with no upper time limit.
- Motor deficit of the upper limb confirmed by the ARAT scale, with the ability to grip and press on a tablet.
- stroke lesion not affecting the motor cortex in the hand knob area.
- Male or female aged 18 years or older on the day of inclusion.
- Affiliated with a social security system, Universal Health Coverage (CMU), or any equivalent scheme.
- Non inclusion criteria
- \-- Pregnant and breastfeeding women
- Conditions that are life-threatening or could compromise follow-up during the study period
- Contraindications to MRI and tACS (ferromagnetic surgical clips, ocular implants, intraocular or nervous system metallic foreign bodies, implants or metallic objects likely to concentrate the radiofrequency field, cochlear implants, brain or cardiac stimulators, presence of a craniotomy scar)
- Participation in another biomedical study during the same period, or current exclusion period from another biomedical study
Criteria the registry did not label
- PATIENTS
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| ICM_ Institut du Cerveau et de la Moelle épinière, Hôpital Pitié, 47 Bd de l'Hôpital Coordinator of this site? Confirm its status | Paris | France | Recruiting |
| ToNIC - Toulouse neuro Imaging center (Inserm)Pavillon Baudot Coordinator of this site? Confirm its status | Toulouse | France | Not yet recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.